Impact of Genetic Variant BDNF (Val66Met) on Brain Structure and Function

Growth Factors and Psychiatric Disorders

Volumn 289, Issue , 2008, Pages 180-188

  Chen, Zhe Yu ^a   Bath, Kevin ^a   McEwen, Bruce ^b   Hempstead, Barbara ^a   Lee, Francis ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Downstream functional change; Gene environment interaction; Hippocampal anatomy and hippocampal dependent learning; Reliable genetic or non genetic biomarkers; Single nucleotide polymorphism (SNP)

Indexed keywords

EID: 84883744473     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470751251.ch14     Document Type: Chapter

References (44)

1. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK 2006 BDNF Val(66)Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59:812-815.
2. Chao MV 2003 Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4:299-309.
3. Chao MV, Rajagopal R, Lee FS 2006 Neurotrophin signalling in health and disease. Clin Sci (Lond) 110:167-173.
4. Chen ZY, Patel PD, Sant G et al 2004 Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24:4401-4411.
5. Chen ZY, Ieraci A, Teng H et al 2005 Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J Neurosci 25:6156-6166.
6. Chen ZY, Jing D, Bath KG et al 2006 Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140-143.
7. Cowley S, Paterson H, Kemp P, Marshall CJ 1994 Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
8. Desai N, Rutherford L, Turrigiano G 1999 BDNF regulates the intrinsic excitability of cortical neurons. Learn Mem 6:284-291.
9. Egan MF, Kojima M, Callicott JH et al 2003 The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269.
10. Farhadi H, Mowla S, Petrecca K, Morris S, Seidah N, Murphy R 2000 Neurotrophin-3 sorts to the constitutive secretory pathway of hippocampal neurons and is diverted to the regulated secretory pathway by coexpression with brain-derived neurotrophic factor. J Neurosci 20:4059-4068.
11. Frodl T, Schule C, Schmitt G et al 2007 Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 64:410-416.
12. Gabrieli JD, Brewer JB, Poldrack RA 1998 Images of medial temporal lobe functions in human learning and memory. Neurobiol Learn Mem 70:275-283.
13. Gratacos M, Gonzalez JR, Mercader JM, Cid RD, Urretavizcaya M, Estivill X 2007 Brainderived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of casecontrol studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61:911-922.
14. Hariri AR, Goldberg TE, Mattay VS et al 2003 Brain-derived neurotrophic factor Val66Met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23:6690-6694.
15. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH 2006 Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 63:731-740.
16. Huang E, Reichardt L 2001 Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677-736.
17. Jiang X, Xu K, Hoberman J et al 2005 BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30:1353-1361.
18. Kaufman J, Yang BZ, Douglas-Palumberi H et al 2006 Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 59:673-680.
19. Kim JM, Stewart R, Kim SW et al 2007 BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging. In press.
20. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T 1995 Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860.
21. Lang UE, Hellweg R, Kalus P et al 2005 Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180:95-99.
22. Lee R, Kermani P, Teng KK, Hempstead BL 2001 Regulation of cell survival by secreted proneurotrophins. Science 294:1945-1948.
23. Lu B 2003a BDNF and activity-dependent synaptic modulation. Learn Mem 100:86-98.
24. Lu B 2003b Pro-region of neurotrophins: role in synaptic modulation. Neuron 39:735-738.
25. Lu B, Pang PT, Woo NH 2005 The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603-614.
26. Mazzucchelli C, Vantaggiato C, Ciamei A et al 2002 Knockout of Erk1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal mediated learning and memory. Neuron 34:807-820.
27. Momose Y, Murata M, Kobayashi K et al 2002 Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 51:133-136.
28. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy J 2002 The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a familybased association study. Am J Hum Genet 71:651-655.
29. Pang PT, Teng HK, Zaitsev E et al 2004 Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306:487-491.
30. Patterson S, Abel T, Deuel T, Martin K, Rose J, Kandel E 1996 Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16:1137-1145.
31. Pezawas L, Verchinski BA, Mattay VS et al 2004 The brain-derived neurotrophic factor Val66Met polymorphism and variation in human cortical morphology. J Neurosci 24:10099-10102.
32. Qui M-S, Green SH 1991 NGF and EGF rapidly activate p21ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylation. Neuron 7:937-946.
33. Rosenblum K, Futter M, Voss K et al 2002 The role of extracellular regulated kinases I/II in late-phase long-term potentiation. J Neurosci 22:5432-5441.
34. Roux PP, Barker PA 2002 Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67:203-233.
35. Schacter DL, Wagner AD 1999 Perspectives: neuroscience. Remembrance of things past. Science 285:1503-1504.
36. Schacter DL, Curran T, Reiman EM, Chen K, Bandy DJ, Frost JT 1999 Medial temporal lobe activation during episodic encoding and retrieval: a PET study. Hippocampus 9:575-581.
37. Sen S, Nesse RM, Stoltenberg SF et al 2003 A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28:397-401.
38. Shimizu E, Hashimoto K, Iyo M 2004 Ethnic difference of the BDNF 196G/A (Val66Met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 126:122-123.
39. Sklar P, Gabriel S, McInnis M et al 2002 Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 7:579-593.
40. Suter U, Heymach J, Shooter E 1991 Two conserved domains in the NGF polypeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF. EMBO J 10:2394-2400.
41. Szeszko PR, Lipsky R, Mentschel C et al 2005 Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10:631-636.
42. Teng HK, Teng KK, Lee R et al 2005 ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25:5455-5463.
43. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P 1992 Sustained activation of the mitogen-activated (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem J 288:351-355.
44. Ventriglia M, Bocchio Chiavetto L, Benussi L et al 2002 Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 7:136-137.